✦ LIBER ✦

Antiangiogenic metronomic therapy for children with recurrent embryonal brain tumors

✍ Scribed by Andreas Peyrl; Monika Chocholous; Mark W. Kieran; Amedeo A. Azizi; Christina Prucker; Thomas Czech; Karin Dieckmann; Maria-Theresa Schmook; Christine Haberler; Ulrike Leiss; Irene Slavc

Book ID: 112168014
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 159 KB
Volume: 59
Category: Article
ISSN: 1545-5009
DOI: 10.1002/pbc.24006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metronomic antiangiogenic therapy in chi

Metronomic antiangiogenic therapy in children with recurrent brain tumours of different histologies

✍ A. Peyrl; M. Chocholous; M.W. Kieran; A.A. Azizi; C. Prucker; T. Czech; K. Dieck 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 196 KB

Efficacy of temozolomide for recurrent e

Efficacy of temozolomide for recurrent embryonal brain tumors in children

✍ Chung-Hao Wang; Ting-Rong Hsu; Tai-Tong Wong; Kai-Ping Chang 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 320 KB

High-dose chemotherapy with autologous s

High-dose chemotherapy with autologous stem cell rescue for children with recurrent malignant brain tumors

✍ Chie-Schin Shih; Gregory A. Hale; Lindsey Gronewold; Xin Tong; Fred H. Laningham 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

## Abstract ## BACKGROUND. High‐dose chemotherapy (HDCT) with autologous stem cell rescue (ASCR) has been reported to be effective in treating children with recurrent central nervous system (CNS) malignancies. ## METHODS. To evaluate the efficacy and toxicities of HDCT and ASCR, the medical reco

Etoposide With or Without Mannitol for t

Etoposide With or Without Mannitol for the Treatment of Recurrent or Primarily Unresponsive Brain Tumors: A Children's Cancer Group Study, CCG-9881

✍ Nathan L. Kobrinsky; Roger J. Packer; James M. Boyett; Philip Stanley; Tania Shi 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 62 KB

Pre-irradiation chemotherapy and hyperfr

Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. A phase II study of the pediatric oncology group, protocol 8833

✍ Cynthia S. Kretschmar; Nancy J. Tarbell; Patrick D. Barnes; Jeffrey P. Krischer; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 982 KB

A Phase I study of granulocyte-macrophag

A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors : A report of the Children's Cancer Group

✍ Mitchell S. Cairo; Mark D. Krailo; Joel A. Weinthal; Rita Secola; Sharon Bergero 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 3 views

## Background: This phase i trial was developed to determine the safety, biologic activity, and effects on hematopoietic recovery of pixy321 following ifosfamide, carboplatin, and etoposide chemotherapy for children with recurrent or refractory solid tumors. ## Methods: Children (age < 22 years a